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Abstract
Objectives: There are safety issues associated with propofol use for flexible bronchoscopy (FB). The bispectral index (BIS)
correlates well with the level of consciousness. The aim of this study was to show that BIS-guided propofol infusion is safe
and may provide better sedation, benefiting the patients and bronchoscopists.
Methods: After administering alfentanil bolus, 500 patients were randomized to either propofol infusion titrated to a BIS
level of 65-75 (study group) or incremental midazolam bolus based on clinical judgment to achieve moderate sedation. The
primary endpoint was safety, while the secondary endpoints were recovery time, patient tolerance, and cooperation.
Results: The proportion of patients with hypoxemia or hypotensive events were not different in the 2 groups (study vs.
control groups: 39.9% vs. 35.7%, p=0.340; 7.4% vs. 4.4%, p=0.159, respectively). The mean lowest blood pressure was lower
in the study group. Logistic regression revealed male gender, higher American Society of Anesthesiologists physical status,
and electrocautery were associated with hypoxemia, whereas lower propofol dose for induction was associated with
hypotension in the study group. The study group had better global tolerance (p,0.001), less procedural interference by
movement or cough (13.6% vs. 36.1%, p,0.001; 30.0% vs. 44.2%, p=0.001, respectively), and shorter time to orientation
and ambulation (11.7610.2 min vs. 29.7626.8 min, p,0.001; 30.0618.2 min vs. 55.7640.6 min, p,0.001, respectively)
compared to the control group.
Conclusions: BIS-guided propofol infusion combined with alfentanil for FB sedation provides excellent patient tolerance,
with fast recovery and less procedure interference.
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Introduction
Patients undergoing flexible bronchoscopy (FB) experience
procedure-related symptoms [1]. Benzodiazepines (i.e., midazo-
lam) plus an opioid is the most common combination used to
improve patient tolerance and satisfaction [2,3]. Current guide-
lines recommend incremental midazolam sedation to all patients
undergoing FB, except when there are contraindications [4]. The
required dose varies, and its prolonged effect delays patient
recovery [5]. Moreover, a bolus of midazolam is often adminis-
tered when patients suffer from procedure related discomfort that
interferes with bronchoscopic procedures.
With the advances in sedative drugs and monitors, several FB
sedative protocols have been recently investigated. Sedation with
intermittent propofol (2,6-diisopropylphenol) bolus has shown to
provide good tolerance and fast recovery in patients undergoing
FB [6,7,8]. Because of its short time to peak concentration (2 min)
and fast redistribution and clearance, propofol is suitable and
easily titratable to maintain steady plasma concentrations with
continuous infusion [9,10]. Adding opioids may provide antitus-
sive effects and modify the pharmacokinetics of propofol, which
reduces the required propofol dose [9,11,12]. Alfentanil is ideal for
FB because of its fast onset and short duration [13,14,15].
However, controversy about combining propofol and opioids
persists because of the risk of over-sedation and cardiopulmonary
depression [16,17].
The bispectral index (BIS) is a non-invasive and objective
indicator of the depth of anesthesia. Its algorithm processes
patients’ electroencephalography (EEG) and electromyography
(EMG) data and computes an index from 0 (isoelectric EEG) to
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concentration, sedative score, and BIS level have been shown
[18,19,20,21], and BIS-guided propofol bolus maintaining a BIS
index between 70 and 85 has been studied in simple FB
procedures [7]. Larger studies are needed to evaluate the feasibility
of BIS-guided propofol sedation in FB. Furthermore, the
increasing use of interventional FB requires more objective and
efficient methods of sedation delivery[22]. Therefore, we designed
a sedative protocol combining the advantages of propofol infusion
and alfentanil, using BIS monitoring to maintain a level of 65 to
75, in order to provide efficient sedation for patients undergoing
complex and long duration procedures.
This study hypothesized that BIS-guided propofol infusion is as
safe as the current standard method of clinically-judged mid-
azolam sedation, and may even provide better FB sedation.
Methods
This prospective, randomized study was conducted in a tertiary
medical center. The institutional review board of the Chang Gung
Memorial Hospital approved the study protocol (No. 97-0257B)
and the enrolled patients provided written informed consent. The
protocol for this trial and supporting CONSORT checklist are
available as supporting information; see Checklist S1 and Protocol
S1. Patients undergoing elective FB and sedation were screened
for enrollment. The exclusion criteria were age ,18 years,
American Society of Anesthesiologists (ASA) physical status
classification IV or V, neurologic disorders or other conditions
contributing to difficulty in assessing response, forced expiratory
vital capacity (FVC) ,15 mL/kg body weight, forced expiratory
volume in one second (FEV1) ,1000 mL or FEV1/FVC ,35%,
or a Mallampati score of 4. Patients with a known history of allergy
to the study drugs, eggs, soybeans or sulfite products, or those with
glaucoma were also excluded. The enrolled patients were
randomized by an investigator according to a predetermined
computer code.
Sample size
A preliminary study following the patient preparation, premed-
ication and sedative protocol was performed before this trial.
Sixteen patients undergoing FB in both groups were analyzed.
The proportion of patients recorded with at least one episode of
desaturation (oxygen saturation ,90% with any duration) in each
group was 0.31 and 0.19, respectively. A difference of .12% in
the percent of patients experiencing desaturation would be
considered clinically important [23]. A sample size of 250 per
group was selected to provide 90% power to detect such a
difference using a two sided 5% level of significance.
Patient preparation
Blood pressure was monitored using an automated pressure
cuff, and heart rate and rhythm were monitored by three-lead
electrocardiography. A peripheral pulse oximeter was used to
monitor oxyhemoglobin saturation (SpO2) while a nasal cannula
delivered 2 L/min of oxygen to the patient. An intravenous
catheter was placed in the forearm for drug administration. A
disposable BIS Quatro Sensor (Aspect Medical System Inc,
Newton, MA, USA) was applied to the forehead of patients in
the study group. The sensor was connected to the A-2000 XP BIS
monitor (Version 3.11, Aspect Medical Systems, Inc.). A BIS value
was displayed once all impedances were acceptable. The
smoothening time was set at 15 s. All parameters were monitored
continuously except for blood pressure, which was recorded every
3 min.
Topical anesthesia with nebulized lidocaine and the ‘‘spray as
you go’’ technique was used for local anesthesia, as described
elsewhere [24]. An experienced bronchoscopist assisted by a well-
trained technician performed the FB. One investigator responsible
for sedation techniques monitored cardiopulmonary functions to
determine the need for interventions, such as increasing the
oxygen delivery to 6 L/min to maintain oxygen saturation above
90%, jaw support, manual assisted ventilation with an ambubag
for persistent desaturation, to maintain adequate airways or fluid
resuscitation, and leg elevation for hypotension.
All bronchoscopists and investigators were qualified for
intensive and critical care and advanced cardiac life support.
They were also familiar with the sedation drugs used for FB
sedation [4]. The resuscitation equipment and drugs were readily
available.
Sedation protocol
In the study group, induction was performed using alfentanil
(1:10 dilution, 4-5 mg/kg bolus) following an initial administration
of 0.5 mg/kg intravenous propofol bolus. The dose of propofol
was then carefully titrated by administering 10–20 mg boluses
until the BIS index reached 70. The duration between boluses was
20 s. The propofol infusion (3–12 mg/kg/h) was then adminis-
tered using a syringe pump (Injectomat Agilia, Fresenius Kabi,
France) to maintain the BIS index between 65 and 75. If cough-
related BIS elevation occurred, cough management was per-
formed as described below, rather than increasing the dose of
propofol.
In the control group, induction was performed using alfentanil
(4–5 mg/kg bolus) following a 2 mg midazolam bolus. According
to official guidelines of FB [4], if the patient was not well-sedated
after 2 min, midazolam bolus was repeated in increments of
1 mg/min until moderate sedation (purposeful response to verbal
or tactile stimulation) was achieved [4,25]. For maintenance,
1 mg/min midazolam boluses were administered based on clinical
judgment to achieve moderate sedation or if persistent patient
movement or severe cough interfered with the procedure.
In both groups, if the bronchoscopist deemed that persistent
cough interfered with the procedure, oral secretions were
suctioned and/or 2 mL 1% lidocaine was instilled via the
bronchoscope. If cough persisted and the management proved
insufficient, an alfentanil bolus (1–2 mg/kg) was administered for
every 15 min. After the procedure, the patients were sent to the
recovery room and monitored continuously until full recovery.
Assessment
Adverse events were evaluated as the proportion of patients with
at least 1 event of hypotension (systolic blood pressure [SBP]
,90 mm Hg or mean arterial blood pressure [MAP] ,60 mm Hg
of any duration) or hypoxemia (SpO2 ,90% of any duration)
during FB. The lowest SpO2 and blood pressure values were also
recorded.
Bronchoscopists assessed patient cooperation in the following
manner. ‘‘Procedural interference by patient movement’’ meant
that the bronchoscopist had to pause the procedure temporarily
and the assistant needed to physically restrain the irritated patient.
‘‘Procedural interference by cough’’ meant that the bronchoscopist
had to pause the procedure temporarily and additional xylocaine
spray and/or alfentanil had to be administered to stop the
coughing.
Recovery was evaluated by time to orientation and time to
ambulation. Time to orientation was defined as the duration
between finishing FB and the point when the patients could
spontaneously open their eyes, recall their date of birth, and
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was defined as the duration between finishing FB and the point
when the patients could walk without assistance. After recovery,
the patients answered a questionnaire regarding procedure-related
symptoms, including nebulized anesthetic inhalation, scope
insertion, cough, dyspnea, pain, and global tolerance to the entire
procedure on a 10-point verbal analogue scale (VAS, 0: no bother,
10: worst intolerable) as recorded by an investigator blinded to
their groupings.
The sedative doses and the duration of induction as well as of
the procedures were recorded. Induction time was defined as the
duration between alfentanil administration and the point when the
desired sedation level was attained. FB duration was defined as the
time period between the insertion and removal of the broncho-
scope. On the third to fifth day post-FB, the general condition of
the patientswas followed up, either by outpatient visits or by
telephone correspondence.
Statistical analysis
Age, body weight, drug doses, and duration were presented as
mean 6 standard deviation (SD) and analyzed by the Student’s t-
test. The VAS was presented as accumulative percentage in each
group, and analyzed by the Mann-Whitney U test. The chi-square
test was used to analyze gender, physical status, indications, and
procedures, as well as adverse events and patient cooperation.
Univariate Student’s t-test and chi-square tests where appropriate
were performed to determine which factors including patient
characteristics, indications of bronchoscopy, procedures per-
formed, sedative dosing of induction/total procedures, and
duration of induction/total procedure were significantly associated
with hypoxemia or hypotension (MAP ,60 mm Hg or SBP
,90 mm Hg) in the study group. All factors significant in
univariate analysis were further analyzed by the multivariate
logistic modeling. Statistical significance was set at p,0.05.
Statistical analyses were performed using the Statistical Package
for Social Sciences version 13 (SPSS Inc., Chicago, IL, USA).
Results
From April 2008 to September 2009, 500 patients undergoing
elective FB were randomized (Figure 1), and 243 and 249 patients
completed the intervention in the study and control groups,
respectively. Both groups had comparable basic characteristics,
indications, and FB procedures (Table S1). More than 75% of
patients were outpatients, and 40% were ASA class 3. More than
70% patients underwent at least two procedures. The major
indications for FB were lung or mediastinal nodules/masses, and
the most common procedure was biopsy (68.3% of all patients) of
the lungs or mediastinum.
The mean duration of FB was 25 min, and the proportion of
patients with hypotension or hypoxemia, as well as the lowest
SpO2 value was similar in both groups (Table 1 and Figure 2). The
mean lowest blood pressure was significantly lower in the study
group, and all recovered spontaneously or following proper
management. Vasopressor administration was not required;
mortality was also not recorded. In the study group, 1 patient
was intubated and mechanical ventilation was performed because
of massive bleeding after bronchial biopsy, and 1 patient
developed a pneumothorax that required chest tube drainage. In
the control group, 1 patient was administered flumazenial for a
poor respiratory pattern during recovery and was admitted to the
intensive care unit. These patients recovered without sequelae. On
following up after 3–5 days, no significant serious complications
were noted in either group. Logistic regression revealed that male
gender, higher ASA physical status, and electrocautery were
associated with hypoxemia and lower induction doses of propofol
were associated with hypotension in the study group (Table 2).
Patients in the study group achieved the desired level of sedation
more rapidly than those in the control group did (Table 1).
Procedure time was similar in both groups, and the mean BIS level
was 70.8 in the study group. Procedural interference by patient
movement or cough was significantly less in the study group
(Figure 3A), and the total dose of alfentanil was higher in the
control group because more supplemental doses were required due
to a higher incidence of severe coughing. Patients in the study
group recovered their orientation faster and were able to walk
without assistance in a shorter time. They also showed significantly
better tolerance for bronchoscope insertion, cough, and dyspnea
during FB, as well as global tolerance for the whole procedure, as
scored by VAS (Figure 3B).
Discussion
To the best of our knowledge, this is the first prospective
randomized study of alfentanil in combination with continuous
propofol infusion titrated to maintain a BIS level of 65–75 for FB
sedation. This study revealed that BIS-guided propofol infusion is
as safe as the current standard method of clinically-judged
midazolam sedation, in terms of the proportion of patients
experiencing hypoxemia and hypotension. The mean lowest blood
pressure was lower in the study group compared to the control
group, and all patients recovered spontaneously or after proper
management. This study proves that BIS-guided propofol sedation
provides better tolerance and faster recovery to patients undergo-
ing FB, and provides faster induction and less procedural
interference for the bronchoscopists. These findings are clinically
valuable, especially for complicated and time-consuming inter-
ventional bronchoscopic procedures.
The BIS algorithm was developed from a large database of
patients or volunteers receiving various anesthetic regimens [19].
However, it has not been applied routinely during FB, and the
optimal BIS level for FB sedation is not yet established. Grass et al.
[19] reported that 95% of healthy volunteers under propofol
sedation become amnesic at a mean BIS level of 77 (95% CI 72–
83), and 50% lose their response to verbal commands at a mean
BIS level of 63 (95% CI 62–65). Bauer et al. [26], in another
propofol sedation study of patients undergoing surgery, reported
that patients could still move in response to pain stimulation when
the mean BIS level was 69. In another study using BIS monitoring
during gastrointestinal endoscopy sedation, Bower et al. [20]
reported that patients responded to mild prodding, which is
considered the level of moderate sedation, at a median BIS level of
67.5 (range, 54–97). Thus, a BIS level of 65–75 was set for FB
sedation, and a BIS level of 70 was set for induction in this
protocol to achieve patients that are amnesic but still with reflex
responsiveness to noxious stimulation at a relatively level of
sedation. If cough-related BIS elevation occurred, coughing was
first treated as mentioned in our method., instead of introducing
propofol.
Recently, Clark et al. [7] compared administration of single
drug bolus of propofol to midazolam while maintaining the BIS
level at 70–85 for a small number of patients undergoing simple
FB with better ASA class. Patients receiving propofol showed
better global tolerance, but no difference in the perception of
coughing and there was no difference in the bronchoscopists’
assessment, comparing to the control patients. Stolz et al. [8]
reported that the discomfort score and safety profiles of patients
receiving sedation for FB with propofol bolus based on clinical
BIS-Guided Propofol Infusion for Bronchoscopy
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P/M dose, mg 54.5 (16.4) 3.8 (2.5)
A dose, mg 295.0 (54.8) 285.2 (56.4) 0.052
Induction time,* min 3.4 (1.6) 5.3 (3.1) ,0.001
Total procedures
P/M dose, mg 198.6 (102.7) 6.8 (3.9)
A dose, mg 325.4 (101.7) 350.3 (117.1) 0.012
Mean BIS level 70.8 (6.1)
Procedure time,{ min 25.8 (15.2) 25.5 (16.2) 0.810
Recovery time, min
Time to orientation{ 11.5 (10.2) 30.0 (26.8) ,0.001
Time to ambulation" 30.0 (18.1) 55.7 (40.6) ,0.001
Safety
#
SpO2 ,90% 97 (39.9) 89 (35.7) 0.340
MAP ,60 mm Hg 11 (4.5) 4 (1.6) 0.060
SBP ,90 mm Hg 18 (7.4) 11 (4.4) 0.159
Data is presented as mean (SD) unless otherwise indicated.
Abbreviations: P, propofol; M, midazolam; A, alfentanil; SpO2: oxyhemoglobin saturation; MAP: mean arterial blood pressure; SBP: systolic blood pressure.
*From alfentanil administration to BIS level 70 in the study group, or conscious sedation in the control group.
{From insertion of bronchoscope to its removal.
{Patients could open eyes spontaneously, correctly recall date of birth, and perform finger-nose test.
"Patients could walk without assistance.
# The number of patients with at least one event of hypoxemia or hypotension during the entire procedure (percent).
doi:10.1371/journal.pone.0027769.t001
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combined midazolam and hydrocodone, although coughing was
more severe with propofol treatment. Compared to these studies,
the FB procedures employed in the current study were more
complicated and time-consuming, but the study revealed that BIS-
guided propofol infusion with alfentanil administration provides
additional benefits for the bronchoscopists (less procedural
interference) and patients (less discomfort from scope insertion,
dyspnea, and cough). Compared to intermittent administration of
boluses, which may result in fluctuating plasma concentrations and
risk of over- or under-sedation, continuous propofol infusion
provides a more steady plasma concentration that can be titrated
within the therapeutic window [9,10,27]. Adding alfentanil can
modify the pharmacokinetic property of propofol, reduce the
required dose of propofol, and facilitate faster recovery with less
cardiovascular depression [9,11,12]. A BIS monitor provides a
trend of EEG change during a short processing time (usually 15 s)
and gives the feedback of conscious level changing fromthe patient
responsiveness to the procedures and drugs, thereby helping
sedative drug adjustment. Thus, a BIS-guided propofol infusion
can provide a steadier drug concentration and effect, as well as
allow instant and individualized titration. This may explain why
BIS-guided sedation was better tolerated and had reduced irritated
movements by patients, without increased adverse effects in this
study. Despite higher doses of propofol, and more complicated
and longer procedures, the incidence of hypotension was similar to
that reported by Clark et al. [7] (3.7–7.4% vs. 4.7%) and that of
hypoxemia (39.9%) was consistent with previous reports (34.9%
and 32%, respectively) [7,8].
Logistic regression revealed that electrocautery, ASA class 3,
and male gender were associated with hypoxemia in the study
group. Electrocautery often generates tissue debris and blooding
that contribute to ventilation/perfusion mismatch in patients with
endobronchial lesions during prolonged procedures. Patients with
higher ASA physical status may have relatively inadequate
cardiopulmonary function. In the current study, men received
more alfentanil during induction than women (310.8 vs. 271.1 mg,
p,0.001) because of higher mean weight (64.4 vs. 56.0 kg,
p,0.001), and had a higher incidence of hypoxemia during
induction (20% vs. 9.2%, p=0.023). The higher amount of
alfentanil administered to men may be a contributing factor to the
increase in the incidence of hypoxemia in men. Another
explanation may be the gender-based difference in the pharma-
cokinetic properties of alfentanil or propofol [28]. However, this
study was not designed to investigate such parameters. For male
patients with ASA physical status 3 or those with endobronchial
obstructions where electrocautery is indicated, propofol infusion
should be performed with caution.
Logistic regression also revealed that a lower induction dose of
propofol was associated with hypotension. Patients who required
less propofol for induction may be more sensitive to propofol. This
may be explained by different interpatient susceptibilities to
propofol due to the difference in cardiac output, hepatic perfusion,
body fat, and haplotype differences in metabolic genes, and
requires to be studied further[29]. This is a valuable hint for
clinical practice. If induction is achieved rapidly, sedative
procedures should be performed with caution. The BIS has been
used to monitor propofol titration for sedation of various
procedures [7,12,20,21]; however, there are other aspects of FB
sedation that require further study. Besides the cost-effectiveness of
the additional equipment and personnel, the regimen of opioid
administration for induction as well as the procedure, the optimal
BIS level for FB sedation, and the propofol infusion profile for
better pharmacokinetic control (e.g., targeted control infusion)
require further investigation to improve FB sedation.
This study has some limitations that should be considered. First,
the investigators and bronchoscopists were not blinded to the
sedation procedures. Because the aim of this study was to compare
the current standard practice of clinically-judged incremental
midazolam sedation to BIS-guided propofol continuous infusion, it
is difficult to use completely blinded conditions because of maior
Figure 2. The mean lowest oxygen saturation and blood
pressure in both groups. Boxes represent median and inter-quartile
range; whiskers represent range. BIS, bispectral index; SpO2, oxyhemo-
globin saturation; MAP, mean arterial blood pressure; SBP, systolic
blood pressure; DBP, diastolic blood pressure.
doi:10.1371/journal.pone.0027769.g002
Table 2. Univariate and logistic regression analysis of factors
associated with hypoxemia or hypotension in patients under
BIS-guided propofol sedation.
Factors OR 95% CI p value
Univariate analysis*
Hypoxemia{
Male vs. female 1.74 1.02–2.96 0.041
ASA physical status 3 vs. 1/2 2.30 1.36–3.90 0.002
Electrocautery 5.10 1.36–19.00 0.015
Hypotension{
Endobronchial obstruction 5.33 1.50–18.89 0.001
Induction dose of propofol 0.96 0.92–0.99 0.019
Electrocautery 5.94 1.65–21.44 0.006
Logistic regression"
Hypoxemia{
Male vs. female 1.75 1.01–3.04 0.047
ASA physical status 3 vs. 1/2 2.20 1.29–3.77 0.004
Electrocautery 5.16 1.34–19.91 0.017
Hypotension{
Induction dose of propofol- 0.96 0.93–1.00 0.041
Abbreviations: OR, odds ratio; CI, confidence interval; ASA, American Society of
Anesthesiologists.
*Patient, procedure, sedative factors were analyzed by univariate Student’s t-
test and chi-square tests where appropriate.
{Oxyhemoglobin saturation ,90% for any duration.
{Mean arterial pressure ,60 mm Hg or systolic blood pressure ,90 mm Hg for
any duration.
"Factors significant in the univariant analysis were analyzed and adjusted
together by the multivariate logistic modeling.
doi:10.1371/journal.pone.0027769.t002
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protocol by observing the actions of the investigators while patients
without irritated motion but BIS level reaching to the criteria for
drug titration. Nonetheless, the primary endpoints were hypoxemia
and hypotension events, which were recorded objectively. Second,
patients with a history of FB were not excluded. Many patients
indications for interventional bronchoscopy often undergo FB first
for lesion site evaluation or for pathologic confirmation. Such
previous experience with FB may affect a patient’s judgment
regarding their tolerance of FB. However, the numbers of patients
Figure 3. Patient cooperation was accessed by procedural interference during bronchoscopy (A) and patient tolerance of
procedure-related symptoms and global tolerance during bronchoscopy was accessed by verbal analogue scale (VAS) (B). A:
Interference by patient movement: The bronchoscopist had to temporarily pause the procedure and the assistants had to restrain the patient.
Interference by patient coughing: The bronchoscopist had to pause the procedure temporarily and additional xylocaine spray and/or alfentanil had
to be administered to stop the coughing. *p,0.001 vs. clinically-judged midazolam; #p=0.001 vs. clinically-judged midazolam. B: After recovery,
patient tolerance was evaluated by VAS (0: no bother, 10: worst intolerable). Data are presented as accumulative percentage of VAS in each group. A
lower VAS score indicates better tolerance.
doi:10.1371/journal.pone.0027769.g003
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not shown); therefore, this should not influence data interpretation.
In conclusion, the current study showed that BIS-guided
propofol infusion combined with alfentanil is feasible and safe. It
provides excellent tolerance and fast recovery for the patients
undergoing FB. It also facilitates the performance of procedures
and reduces patient interference. Further studies on induction, BIS
level, and propofol infusion profile for FB sedation as well as cost-
effectiveness of BIS guided propofol infusion are warranted to
improve the safety and quality of FB sedation.
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